CID 139377809

Sunvozertinib

Structural Information

Molecular Formula
C29H35ClFN7O3
SMILES
CC(C)(C1=CC(=C(C=C1NC2=NC(=NC=C2)NC3=C(C=C(C(=C3)NC(=O)C=C)N4CC[C@H](C4)N(C)C)OC)Cl)F)O
InChI
InChI=1S/C29H35ClFN7O3/c1-7-27(39)34-22-14-23(25(41-6)15-24(22)38-11-9-17(16-38)37(4)5)35-28-32-10-8-26(36-28)33-21-13-19(30)20(31)12-18(21)29(2,3)40/h7-8,10,12-15,17,40H,1,9,11,16H2,2-6H3,(H,34,39)(H2,32,33,35,36)/t17-/m1/s1
InChIKey
BTMKEDDEMKKSEF-QGZVFWFLSA-N
Compound name
N-[5-[[4-[5-chloro-4-fluoro-2-(2-hydroxypropan-2-yl)anilino]pyrimidin-2-yl]amino]-2-[(3R)-3-(dimethylamino)pyrrolidin-1-yl]-4-methoxyphenyl]prop-2-enamide
Related CIDs

2D Structure

compound 2d structure
4
Annotation Hits

4
References

904
Patents

583.2474 Da
Monoisotopic Mass

5.0
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 584.25468 242.1
[M+Na]+ 606.23662 246.1
[M-H]- 582.24012 250.3
[M+NH4]+ 601.28122 242.9
[M+K]+ 622.21056 240.0
[M+H-H2O]+ 566.24466 229.4
[M+HCOO]- 628.24560 253.5
[M+CH3COO]- 642.26125 269.4
[M+Na-2H]- 604.22207 238.7
[M]+ 583.24685 243.9
[M]- 583.24795 243.9
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe